The GenomIT team is made up of professionals from diverse disciplines, working together to bring precision medicine closer to doctors, institutions, and patients. We bring together clinical geneticists, molecular biologists, data scientists, bioinformaticians, and systems engineers. We combine clinical knowledge, genomic research, and computational tools to improve people’s health.
We are pioneers in genetic study design and active contributors to innovative biomedical research. Our work is structured in cross-functional teams spanning research, clinical development, and data science.
At our core is a unique dialogue between scientific rigor, data intelligence, and clinical sensitivity.
We’re always looking for people who want to make a real impact.
We began as an Argentine company focused on genetic research. Over time, we evolved into a leading force in biomedical innovation—working with hospitals, labs, universities, professionals, and patients to turn data into decisions that matter.
Our AI platform for cancer biomarker discovery earned us a place in a Stanford University competition and a presentation in Silicon Valley. WATCH VIDEO
GenomIT was born as a spin-off, founded to apply genetics and data science to real-world health problems.
2017 – Launch of Zoigen Lab
Our first business unit: the first platform in the region to turn raw DNA into clinically actionable reports. Zoigen is now a leader in clinical and reproductive genetics across Latin America.
2024 – New Genomer Offices
We expanded from remote work to local offices in La Plata and Buenos Aires—broadening our reach and strengthening our services.
2020–2024 – Scalable health tech
From custom diagnostic solutions to AI-powered platforms for treatment optimization, we’ve created tools tailored to medicine’s most complex needs.
A major milestone: processing and structuring institutional genetic data for use in personalized medicine.
READ PUBLICATION
We continue building disruptive, ethical, and human-centered solutions for a more precise future in medicine.
We collaborate with universities, medical centers, and leading organizations to generate knowledge and scientific evidence, as well as to validate our technologies and enhance their clinical impact.
2020 – Genomer Team Formation
We built an interdisciplinary team of doctors, biologists, developers, data scientists, and bioinformaticians focused on applied health innovation.
2017 – Award-winning research group
Our AI platform for cancer biomarker discovery earned us a place in a Stanford University competition and a presentation in Silicon Valley.WATCH VIDEO
2017 – Purpose-built beginnings
GenomIT was born as a spin-off, founded to apply genetics and data science to real-world health problems.
2017 – Launch of Zoigen Lab
Our first business unit: the first platform in the region to turn raw DNA into clinically actionable reports. Zoigen is now a leader in clinical and reproductive genetics across Latin America.
2020 – Partnership with Hospital Italiano de Buenos AiresA major milestone: processing and structuring institutional genetic data for use in personalized medicine.
READ PUBLICATION
2020 – Genomer Team FormationWe built an interdisciplinary team of doctors, biologists, developers, data scientists, and bioinformaticians focused on applied health innovation.
2020–2024 – Scalable health techFrom custom diagnostic solutions to AI-powered platforms for treatment optimization, we’ve created tools tailored to medicine’s most complex needs.
Institutional PartnershipsWe collaborate with universities, medical centers, and leading organizations to generate knowledge and scientific evidence, as well as to validate our technologies and enhance their clinical impact.
2024 – New Genomer OfficesWe expanded from remote work to local offices in La Plata and Buenos Aires—broadening our reach and strengthening our services.
Now – Looking aheadWe continue building disruptive, ethical, and human-centered solutions for a more precise future in medicine.